ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 101 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $675,523 | -45.7% | 140,734 | -15.0% | 0.00% | – |
Q2 2023 | $1,243,288 | +82.8% | 165,551 | +10.0% | 0.00% | – |
Q1 2023 | $680,133 | -62.3% | 150,472 | -5.9% | 0.00% | -100.0% |
Q4 2022 | $1,803,031 | +24.3% | 159,985 | +5.6% | 0.00% | 0.0% |
Q3 2022 | $1,450,000 | +18.1% | 151,502 | -0.1% | 0.00% | – |
Q2 2022 | $1,228,000 | -45.6% | 151,713 | +13.7% | 0.00% | -100.0% |
Q1 2022 | $2,256,000 | -25.0% | 133,479 | -4.6% | 0.00% | 0.0% |
Q4 2021 | $3,007,000 | -70.6% | 139,882 | +0.8% | 0.00% | -66.7% |
Q3 2021 | $10,245,000 | +102.1% | 138,706 | +49.6% | 0.00% | +50.0% |
Q2 2021 | $5,070,000 | -24.4% | 92,704 | +1.9% | 0.00% | 0.0% |
Q1 2021 | $6,709,000 | +8.0% | 90,970 | +26.3% | 0.00% | 0.0% |
Q4 2020 | $6,210,000 | +184.0% | 72,031 | +24.4% | 0.00% | +100.0% |
Q3 2020 | $2,187,000 | – | 57,924 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 9,699,925 | $715,272,000 | 67.97% |
Logos Global Management LP | 3,156,981 | $232,796,000 | 22.72% |
Vivo Capital, LLC | 4,220,048 | $311,186,000 | 10.94% |
Foresite Capital Management IV, LLC | 785,945 | $57,956,000 | 6.94% |
Foresite Capital Management V, LLC | 320,000 | $23,597,000 | 6.94% |
Board of Trustees of The Leland Stanford Junior University | 518,822 | $38,258,000 | 3.38% |
Cormorant Asset Management, LP | 881,770 | $65,022,000 | 1.45% |
Redmile Group, LLC | 978,600 | $72,162,000 | 1.02% |
SPHERA FUNDS MANAGEMENT LTD. | 130,351 | $9,612,000 | 0.74% |
Artal Group S.A. | 525,000 | $38,714,000 | 0.68% |